IntoCell, Inc. (KOSDAQ:287840)
South Korea
· Delayed Price · Currency is KRW 39,250
-900 (-2.24%)
At close: Apr 28, 2026
IntoCell Market Cap
IntoCell has a market cap or net worth of 589.61 billion as of April 28, 2026.
Market Cap
589.61B
Enterprise Value
569.03B
Revenue
2.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
39,250.00
Market Cap Chart
Since May 23, 2025, IntoCell's market cap has increased from 492.33B to 589.61B, an increase of 19.76%. That is a compound annual growth rate of 21.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 589.61B | -31.52% |
| Dec 30, 2025 | 861.05B | 74.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kanaph Therapeutics | 492.95B |
| HansBiomed | 472.76B |
| IMBiologics | 792.00B |
| S.Biomedics | 424.81B |
| Inventage Lab | 861.70B |
| Curocell | 938.44B |
| Kangstem Biotech | 386.56B |
| Y-Biologics | 371.10B |